Industry News, Trustworthy Insights

Popular Companies:

Goldman Sachs, Morgan Stanley: Advisory on $4.2bn Lifesciences Acquisition Explained

Goldman Sachs and Morgan Stanley are advising BD’s acquisition of Edwards Lifesciences’ Critical Care Product Group for $4.2 billion.

Goldman Sachs signage at the New York Stock Exchange. PHOTO: Corbis/Getty images
Goldman Sachs signage at the New York Stock Exchange. PHOTO: Corbis/Getty images

This move enhances BD’s portfolio with advanced patient monitoring technologies and AI-enabled clinical decision tools. BD, a global medical technology leader, has agreed to buy the Critical Care division from Edwards Lifesciences. Specializing in advanced monitoring solutions, this division includes innovations like

Industry news used by professionals

Try £4.99 per month

Already a member?
Weekly Digest

All the week’s industry events straight to your inbox.

Before your sign up, please read terms of use and privacy policy.

Trending

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to our terms of use and privacy policy.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Password Reset

You will soon receive a Reset Password link

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to terms of use and privacy policy.

Send us your article

[formidable id=3]